• BioPlus controlling shareholder Jung Hyun Kyu raised his stake to 18,388,223 shares, or 29.82%, from 29.58% previously.
• Disclosure date Oct. 8, 2026; obligation-trigger date Sept. 30, 2026.
• Change driven by open-market purchases by a related party; shift in special-related persons followed an executive resignation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioPlus Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000439), on October 08, 2026, and is solely responsible for the information contained therein.